top of page
MDBiologix

Regenerative Research Roundup - October 2024


Welcome to the Regenerative Research Roundup, where we look through recently published research and bring you the best of the best in a quick-to-read digest.


This month, we cover:

  1. Microfragmented adipose tissue for knee osteoarthritis

  2. Platelet-rich plasma dosing for knee osteoarthritis

  3. Autologous protein solution for knee osteoarthritis

  4. Corticosteroid vs hyaluronic acid vs platelet-rich plasma for knee osteoarthritis


Let's dive in!


 

Microfragmented Adipose Tissue Injection for Knee Osteoarthritis


Arthroscopy // LOE: I


This randomized controlled trial evaluated microfragmented adipose tissue (MFAT) injections compared to corticosteroid (CS) and saline control for knee osteoarthritis.


Key findings:


  • MFAT showed consistent and statistically significant improvements in pain and function compared to saline control at all follow-up points out to 1 year

  • MFAT demonstrated continued improvement over 1 year, while CS effects peaked at 2 weeks and declined thereafter

  • At 1 year, MFAT had significantly better outcomes than both CS and saline control


The authors conclude MFAT may be a viable alternative treatment for knee OA patients who fall into the "treatment gap" between conservative measures and surgery.


 

Optimizing Platelet-Rich Plasma Dosing for Knee Osteoarthritis

Current Reviews in Musculoskeletal Medicine // LOE: IV


This systematic review and meta-analysis examined the effect of platelet dose on outcomes after PRP injection for knee osteoarthritis.


Key findings:


  • A dose-response relationship was found between platelet quantity and PRP effectiveness

  • Doses >10 billion platelets showed the best clinical outcomes

  • The effect was more pronounced for functional outcomes than pain relief

  • Lower doses (5-10 billion platelets) showed some benefit over control but less than higher doses


The authors conclude that higher platelet doses (>10 billion) may be optimal for knee OA treatment with PRP, though more research is needed to confirm ideal dosing.


 


Autologous Protein Solution for Knee Osteoarthritis


Bone & Joint Journal // LOE: l


This randomized controlled trial evaluated the efficacy of a specific autologous protein solution (APS) injection called nSTRIDE compared to saline placebo for moderate knee osteoarthritis.


Key findings:


  • No significant differences were found between APS and saline in WOMAC or KOOS scores at any timepoint out to 12 months

  • APS injection resulted in significantly worse pain symptoms at 12 months compared to saline on VAS pain scales

  • No adverse events were recorded in either group


The authors conclude that this particular APS product showed no benefit over placebo and may even worsen pain long-term in knee OA patients.


 


Corticosteroid vs Hyaluronic Acid vs Platelet-Rich Plasma for Knee Osteoarthritis


EFORT Open Reviews // LOE: lV


This systematic review and meta-analysis compared outcomes of corticosteroid (CS), hyaluronic acid (HA), and platelet-rich plasma (PRP) injections for knee osteoarthritis.


Key findings:


  • CS and HA showed similar clinical benefits, with HA having slightly better long-term pain relief

  • PRP demonstrated superior outcomes to both CS and HA, especially at longer follow-up times

  • PRP's benefits were both statistically significant and clinically relevant compared to CS/HA

  • Higher PRP doses (>10 billion platelets) showed the best outcomes



The authors conclude that while CS and HA offer some short-term benefit, PRP appears to be the most effective injectable option for knee OA, especially at higher doses.


 


 

If you have any questions or comments regarding the above research, or are wondering how you can apply it to your regenerative practice, please leave a comment below or shoot me an email at cdowns@mdbiologix.com

Cheers!

Connor

 

This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and any related subjects. The views and opinions expressed in this post are those of the author and may not reflect the views and opinions of MDBiologix. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if any treatment is right for you.

Comments


bottom of page